05/23/2024 4:00 PM | Legend Biotech (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/13/2024 6:01 AM | Legend Biotech (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/22/2024 12:06 PM | Legend Biotech (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/16/2024 6:29 AM | Legend Biotech (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/08/2024 6:03 AM | Legend Biotech (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/05/2024 11:18 AM | BlackRock Inc. (Filed by) Legend Biotech (Subject)
| Form SC 13G/A | |
03/29/2024 7:00 AM | Legend Biotech (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
|
03/26/2024 4:22 PM | Ji Darren Xiaohui (Reporting) Legend Biotech (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
03/25/2024 3:57 PM | Huang Ying (Reporting) Legend Biotech (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
03/19/2024 10:09 AM | Legend Biotech (Subject) Yau Wai Man Philip (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
03/19/2024 6:57 AM | Legend Biotech (Filer)
| Form F-3ASR | |
03/19/2024 6:02 AM | Legend Biotech (Filer)
| Form 20-F Registration statement / Annual report / Transition report | |
03/15/2024 2:18 PM | Legend Biotech (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/13/2024 7:36 AM | Legend Biotech (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/11/2024 6:52 AM | Legend Biotech (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
02/28/2024 5:46 PM | Huang Ying (Reporting) Legend Biotech (Subject)
| Form 144/A | |
02/28/2024 4:35 PM | Huang Ying (Reporting) Legend Biotech (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/27/2024 6:47 PM | Huang Ying (Reporting) Legend Biotech (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/23/2024 12:10 PM | Huang Ying (Reporting) Legend Biotech (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/23/2024 6:16 AM | Legend Biotech (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
02/14/2024 7:34 PM | GenScript Biotech Corp (Filed by) Legend Biotech (Subject)
| Form SC 13G/A | |
01/29/2024 4:25 PM | BlackRock Inc. (Filed by) Legend Biotech (Subject)
| Form SC 13G | |
01/23/2024 8:00 AM | Legend Biotech (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
01/23/2024 6:30 AM | Legend Biotech (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/27/2023 9:00 AM | Legend Biotech (Subject) Yau Wai Man Philip (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
12/22/2023 2:38 PM | Huang Ying (Reporting) Legend Biotech (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
12/22/2023 2:21 PM | Legend Biotech (Subject) Macomber Lori (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
12/21/2023 4:17 PM | Legend Biotech (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/12/2023 1:31 PM | Heyman Tomas J. (Reporting) Legend Biotech (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
11/20/2023 5:02 AM | Legend Biotech (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
11/13/2023 7:30 AM | Legend Biotech (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
10/17/2023 4:39 PM | Huang Ying (Reporting) Legend Biotech (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
10/17/2023 4:50 PM | Huang Ying (Reporting) Legend Biotech (Subject)
| Form 144/A | |
10/17/2023 7:00 AM | Legend Biotech (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
10/16/2023 4:20 PM | Huang Ying (Reporting) Legend Biotech (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
09/27/2023 11:02 AM | Huang Ying (Reporting) Legend Biotech (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
09/25/2023 7:00 AM | Legend Biotech (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/22/2023 3:10 PM | Huang Ying (Reporting) Legend Biotech (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
09/22/2023 3:20 PM | Legend Biotech (Subject) Macomber Lori (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
09/18/2023 3:41 PM | Huang Ying (Reporting) Legend Biotech (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
08/28/2023 9:00 AM | Legend Biotech (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
Gold Set to EXPLODE! (Ad) Gold has already reached all-time highs, and experts believe it's not slowing down any time soon.
In fact, some analysts predict a $7,000 price tag by 2025. Click here now to download the free Precious Metals Buying Guide! |
08/23/2023 3:27 PM | Legend Biotech (Subject) Sanders Corazon D. (0001796536) (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
08/15/2023 5:10 AM | Legend Biotech (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
07/20/2023 7:00 AM | Legend Biotech (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/26/2023 9:30 AM | Legend Biotech (Subject) Yau Wai Man Philip (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
06/07/2023 12:45 PM | Huang Ying (Reporting) Legend Biotech (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
06/06/2023 3:44 PM | Legend Biotech (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/06/2023 2:00 PM | Huang Ying (Reporting) Legend Biotech (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
06/05/2023 10:17 AM | Legend Biotech (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/01/2023 3:18 PM | Huang Ying (Reporting) Legend Biotech (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |